INJECTION FREQUENCY AND PROGNOSTIC FACTORS IN A TREAT-AND-EXTEND REGIMEN OF INTRAVITREAL RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

被引：0
|
作者：
Narayan, Daniel [1 ]
Muecke, James [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2013年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Aki Kato
    Tsutomu Yasukawa
    Iichiro Sugita
    Munenori Yoshida
    Miho Nozaki
    Yoshio Hirano
    Junko Kondo
    Tomohiro Abe
    Kimiko Sugita
    Takahide Okita
    Hiroshi Morita
    Noriaki Takase
    Yuichiro Ogura
    Advances in Therapy, 2022, 39 : 1403 - 1416
  • [2] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Kato, Aki
    Yasukawa, Tsutomu
    Sugita, Iichiro
    Yoshida, Munenori
    Nozaki, Miho
    Hirano, Yoshio
    Kondo, Junko
    Abe, Tomohiro
    Sugita, Kimiko
    Okita, Takahide
    Morita, Hiroshi
    Takase, Noriaki
    Ogura, Yuichiro
    ADVANCES IN THERAPY, 2022, 39 (03) : 1403 - 1416
  • [3] Assessment of Mental Burden of Patients with Neovascular Age-Related Macular Degeneration Treated by Treat-and-Extend Regimen with Intravitreal Ranibizumab
    Kato, Aki
    Yasukawa, Tsutomu
    Sugita, Iichiro
    Yoshida, Munenori
    Nozaki, Miho
    Hirano, Yoshio
    Kondo, Junko
    Abe, Tomohiro
    Sugita, Kimiko
    Okita, Takahide
    Morita, Hiroshi
    Sugitani, Kazuhiko
    Usui, Hideaki
    Niwa, Naomi
    Kato, Fusae
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [4] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [5] Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab
    Abdelfattah, Nizar S.
    Al-Sheikh, Mayss
    Pitetta, Sean
    Mousa, Ahmed
    Sadda, SriniVas R.
    Wykoff, Charles C.
    OPHTHALMOLOGY, 2017, 124 (02) : 215 - 223
  • [6] A systematic review to assess the 'treat-and-extend' dosing regimen for neovascular age-related macular degeneration using ranibizumab
    Rufai, S. R.
    Almuhtaseb, H.
    Paul, R. M.
    Stuart, B. L.
    Kendrick, T.
    Lee, H.
    Lotery, A. J.
    EYE, 2017, 31 (09) : 1337 - 1344
  • [7] A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab
    S R Rufai
    H Almuhtaseb
    R M Paul
    B L Stuart
    T Kendrick
    H Lee
    A J Lotery
    Eye, 2017, 31 : 1337 - 1344
  • [8] Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration Results with Ranibizumab from the TREND Study
    Silva, Rufino
    Berta, Andras
    Larsen, Michael
    Macfadden, Wayne
    Feller, Chrystel
    Mones, Jordi
    OPHTHALMOLOGY, 2018, 125 (01) : 57 - 65
  • [9] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
  • [10] Reactivation of stable neovascular age-related macular degeneration following treat-and-extend regimen discontinuation
    Artiaga, Jose Carlo M.
    Wong, Shiao Wei
    Menon, Deepthy
    Kumar, Swetha
    Dhoble, Pankaja
    Thottarath, Sridevi
    Nicholson, Luke
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2025, 53 (01): : 76 - 83
12345